Remove Hospital Remove Medical Remove Treatments
article thumbnail

Study Explores Virus-based Therapy for Neoadjuvant Treatment of BCC

The Dermatology Digest

TVEC has only been approved for the treatment of superficial melanoma metastases. The treatment was well tolerated by the patients,” says the principal investigator Christoph Hller, Head of the Skin Tumour Centre at the Department of Dermatology at the Medical University of Vienna in Vienna, Austria, in a news release.

Therapy 67
article thumbnail

2025 travel & wellness trends according to the experts

Spa Executive

We asked global wellness and hospitality experts this question: What trends do you see emerging in wellness and travel for 2025, and how can hotels and spas prepare and adapt? Here’s what our experts had to say about the ways hospitality businesses are reshaping their approaches to meet the evolving expectations of today’s traveler in 2025.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

U.S. FDA Clears Avita Medical’s Cohealyx for Healing Full-thickness Wounds

The Dermatology Digest

Branded by AVITA Medical and co-developed with Regenity Biosciences, Cohealyx may reduce treatment timelines, and improve patient outcomes in the treatment of full-thickness wounds. FDA Clears Avita Medicals Cohealyx for Healing Full-thickness Wounds appeared first on The Dermatology Digest. The post U.S.

article thumbnail

Maui Derm News: DecisionDx-SCC Improves Risk Stratification Among Patients With SCC Tumors on the Head or Neck When Combined With BWH Staging

The Dermatology Digest

.’s DecisionDx-SCC test improves risk stratification of patients with cutaneous squamous cell carcinoma (SCC) tumors located on the head or neck when the tests results are combined with Brigham and Womens Hospital (BWH) staging, new research shows.

article thumbnail

New Paradigms for the Treatment of Cutaneous Squamous Cell Carcinoma (cSCC) With Emily S. Ruiz, MD

The Dermatology Digest

The post New Paradigms for the Treatment of Cutaneous Squamous Cell Carcinoma (cSCC) With Emily S. Dr. Ruiz gave a talk on this topic at the American Academy of Dermatologys 2025 Annual Meeting in Orlando, FL.

article thumbnail

Torqur AG’s Bimiralisib Gel Shows Promise in AK

The Dermatology Digest

In the study, 70% of AK patients in the 4-week treatment group (Arm B, 17 patients) and 50% in the 2-week treatment group (Arm A, 18 patients) showed significant improvement in AK lesions. These encouraging interim findings further validate the need for effective, targeted therapies addressing the PI3K pathway in Actinic keratosis.

article thumbnail

Dupilumab (Dupixent, Sanofi & Regeneron) Shows More Promise in BP

The Dermatology Digest

During treatment, all patients underwent a protocol-defined OCS tapering regimen if control of disease activity was maintained. Sustained disease remission was defined as complete clinical remission with completion of OCS taper by week 16 without relapse and no rescue therapy use during the 36-week treatment period.